China Sinopharm International Corporation is a wholly-owned subsidiary of China National Pharmaceutical Group. According to the overall strategic plan of Sinopharm, Sinopharm International undertakes the responsibility to accelerate the development of both international business and domestic pharmaceutical and healthcare industry as well. We exports more than 500 types of products which cover API for human use and vet use, pharmaceutical intermediates, vaccine, diagnostic reagent etc.